Tuesday, December 27, 2022, 12:02 p.m.
Open report of world-class scientists, more doses of mRNA vaccines increase the risk.
27 December 2022 Medical Genome Center Ramathibodi Hospital or the Center for Medical Genomics posted a message about the effectiveness of “Booster vaccine” has the following content…
the effectiveness of “Booster vaccine”, the second generation of mRNA “bivalent” from actual use in a population of more than 50,000 people to prevent infection with COVID-19
Update 27/12/2022 time 10:05
Dr. Nabin K Shrestha and the infectious disease research team from the Cleveland Clinic which is a not-for-profit educational medical center. Located in Cleveland, Ohio, USA. presented research (prepare for publication) This is new research that has not been evaluated by an expert/peer review panel and should not be used as a guide to clinical practice.) Based on real world data of injections. The “bivalent Vaccine Booster Shot”, a second-generation mRNA booster shot, was collected from 51,011 working-age workers (mean age 42.3 years) of the “Cleveland Clinic” who had previously received received the first mRNA vaccine and was infected with COVID-19 natural before Between December 2020-2022, it was found that when receiving a second-generation mRNA vaccine, bivalent (bivalent Vaccine Booster Shot), starting from September 12, 2022, it can stimulate immunity that is effective in preventing infection. COVID-19 30% in 3 months
By that time, Ohio and neighboring states There have been outbreaks of emerging subspecies of omikron BQ.1.1, BQ.1, BA.5,XBB,BF.7, BN.1, and BA.2.75. Hundreds of these strains were reported last week. per 40.7,28.9,8.9,6.2,5.8,4.2 and 1.3 respectively
But what was unexpected for the research team was the risk of contracting COVID-19. Instead, there was a direct variation in the number of times or doses of (mRNA) vaccination. The risk of contracting COVID-19 will be even higher
The researchers tried to come up with a simple explanation for the possibility that the majority of people receiving multiple doses of the vaccine are at high risk of contracting COVID-19. (So it’s important to come in for multiple injections of vaccination)
This study is not the first study. (It has been shown that high doses of the mRNA vaccine increase the risk of contracting COVID-19), but there is also a previous study that collected data from hundreds of thousands of volunteers in the country. Qatar found that people who received three doses of the mRNA vaccine had a higher risk of reinfection with Omicron than those who received two doses of the vaccine. Two or three doses of mRNA vaccine were associated with a higher risk of reinfection than those receiving a single mRNA vaccine.
These findings may suggest that vaccination stimulates the body to build immunity using specific strains of COVID. Narrow-Spectrum Anti-coronavirus Vaccines Imprinted SARS-CoV-2 humoral immunity only to capture and destroy this strain. The resulting immunity may be impaired if those individuals receive a repeat booster shot of the same strain of virus. and later re-infection (breakthrough SARS-CoV-2 infection) with emerging strains of COVID with different mutations (from the strains used for vaccine production)
These findings do not preclude the short-term benefit of booster vaccination. Rather, it is the catalyst for experts around the world to realize and pay attention to studying the human immune system when stimulated by vaccines or from natural infections that are complex in all aspects, in all dimensions, to arrive at conclusions. clear in the management of vaccine types Number of times (doses) of vaccination including injection distance It will also catalyze the development of a vaccine that can prevent infections that cover the original strain. The current epidemic species and new species that will emerge in the future (Broad-Spectrum Anti-coronavirus Vaccines) to ensure that vaccinated people receive the efficacy of each type of vaccine in preventing COVID-19 infection.
Effectiveness of the Coronavirus Disease 2019 (COVID-19) Bivalent Vaccine. Available at:
https://www.medrxiv.org/con…/10.1101/2022.12.17.22283625v1
Chemaitelly H, Ayoub HH, Tang P, et al. COVID-19 primary series and booster vaccination and immune imprinting. 2022:2022.10.31.22281756. Chemaitelly H, Ayoub HH, Tang P, et al. COVID-19 primary series and booster vaccination and immune imprinting. 2022:2022.10.31.22281756. Available at: https://www.medrxiv.org/con…/10.1101/2022.10.31.22281756v1
Shrestha NK, Shrestha P, Burke PC, Nowacki AS, Terpeluk P, Gordon SM. Coronavirus Disease 2019 Vaccine Boosting in Previously Infected or Vaccinated Individuals (COVID-19). Clin Infect Dis 2022; :ciac327.